神经退行性疾病中的神经适应:补偿机制和治疗方法
Spandana Rajendra Kopalli1, Tapan Behl2, Lalji Baldaniya3
1Department of Bioscience and Biotechnology, Sejong University, Gwangjin-gu, Seoul 05006, Republic of Korea.
Progress in neuro-psychopharmacology & biological psychiatry
|April 25, 2025
概括
神经适应是大脑的大脑.
科学领域:
- 神经科学是一个神经科学.
- 细胞生物学 细胞生物学
- 神经退行性疾病 神经退行性疾病
背景情况:
- 像阿尔茨海默氏症和帕金森症这样的神经退行性疾病 (NDD) 涉及渐进的神经元损失.
- 神经适应,大脑重组的能力,是延迟症状出现的关键.
- 机制包括化,神经发生,突触可塑性和神经营养因子变化.
研究的目的:
- 检查NDD中神经适应的分子,细胞和系统过程.
- 了解神经适应机制如何变得不适应.
- 审查针对神经适应的当前和新兴治疗策略.
主要方法:
- 关于阿尔茨海默氏症,帕金森症,亨廷顿症和ALS中神经适应的文献评论.
- 对大脑重组背后的分子和细胞机制的分析.
- 检查药理和非药理治疗干预措施.
主要成果:
- 神经适应包括轴突发芽,树突重塑和神经递质系统变化.
- 这些适应可以变得不适应,导致疾病的进展.
- 氧化应激和神经炎症等因素限制了神经适应,特别是在老年人中.
结论:
- 神经适应在NDD中起着双重作用,提供补偿性和潜在的有害影响.
- 治疗策略旨在通过药理和非药理手段增强有益的神经适应.
- 未来的研究重点是个性化医学和生物标志物,以优化神经适应和改善患者的结果.
关键词:
AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD ADD was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was这就是ALS.在这里,我们可以看到HD HD HD HD.在 LTP LTP 中.警方 警方 警方 警方突触性可塑性 突触性可塑性相关概念视频
Neuroplasticity
245
Neuroplasticity reflects the brain's remarkable capacity to adapt and evolve, responding dynamically to learning, experiences, or injury by reorganizing its neural circuitry. This reorganization involves creating new neural connections and refining old ones through a series of biological processes that contribute to the brain's lifelong development and adaptability.
245
Alzheimer's Disease: Treatment
128
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
128
Alzheimer's Disease: Overview
317
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
317
Parkinson's Disease: Overview
310
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
310
Neurogenesis and Regeneration of Nervous Tissue
668
In the CNS, neurogenesis, the birth of new neurons from stem cells, is limited to the hippocampus in adults. In other regions of the brain and spinal cord, neurogenesis is almost non-existent due to inhibitory influences from neuroglia, especially oligodendrocytes, and the absence of growth-stimulating cues. The myelin produced by oligodendrocytes in the CNS inhibits neuronal regeneration. Furthermore, astrocytes proliferate rapidly after neuronal damage, forming scar tissue that physically...
668
Neural Regulation
39.0K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.0K


